About Us
Pioneers in precision genomics
Foresight Diagnostics was founded by four Stanford University physicians and scientists who sought to develop high-performing circulating tumor DNA (ctDNA) assays by improving the limits of detection through innovative techniques and enhanced bioinformatics. Our first product, Foresight CLARITY™, utilizes a proprietary and patented phased variant (PV) detection method to improve the accuracy of ctDNA tests and minimal residual disease (MRD) measurement.
Since our founding in 2020…
Authored 30+ scientific publications and presentations
Raised $86M from institution VC’s
Partnered with 25+ biopharma and academic researchers
Established an automated and scalable CLIA-registered lab in Boulder, Colorado
Our Investors
Leadership
Chief Medical Officer, Head of Research, Founder
Chief Executive Officer, Chief Scientific Officer, Founder
Chief Operations Officer, Chief Compliance Officer
Chief Business Officer
General Counsel
Senior Vice President, Development and Engineering
Senior Vice President, Business and Laboratory Operations and Strategy
Senior Vice President, Compliance, Public Policy, and Communications
Vice President, Marketing
Vice President, Information Technology and Security
Vice President, Human Resources
Board of Directors
Chief Executive Officer, Chief Scientific Officer, Founder
Scientific Advisor, Founder, Board Member
Board Member
Board Member
Board Member
Board Observer
Scientific Advisory Board
Founder
Scientific Advisor, Founder, Board Member
Scientific Advisory Board Member
Scientific Advisory Board Member
Business Advisor